Effect of non-peptide corticotropin-releasing factor receptor type 1 antagonist on adrenocorticotropic hormone release and interleukin-1 receptors followed by stress

Brain Research

Volumn 902, Issue 1, 2001, Pages 119-126

  Pournajafi Nazarloo, Hossein ^a   Takao, Toshihiro ^a   Nanamiya, Wakako ^a   Asaba, Koichi ^a   De Souza, Errol B ^b   Hashimoto, Kozo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b SANOFI   (France)

Author keywords

Adrenocorticotropic hormone; Corticosterone; Corticotropin releasing factor antagonist; Ether laparotomy; Interleukin 1 receptor

Indexed keywords

4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; CORTICOTROPIN; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DRUG ACTIVITY; DRUG EFFECT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LAPAROTOMY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; SURGICAL STRESS;

ADJUVANTS, IMMUNOLOGIC; ADRENOCORTICOTROPIC HORMONE; ANESTHETICS, INHALATION; ANIMALS; CORTICOSTERONE; ETHER, ETHYL; GENE EXPRESSION REGULATION; INTERLEUKIN-1; LAPAROTOMY; LIPOPOLYSACCHARIDES; MICE; NERVE TISSUE PROTEINS; PITUITARY GLAND, ANTERIOR; PITUITARY-ADRENAL SYSTEM; PYRIDINES; PYRIMIDINES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, INTERLEUKIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS;

EID: 0035947047     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02383-6     Document Type: Article

References (33)

1. Non-peptide corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: Evidence that increase in arousal induced by stress is mediated through CRH receptor type 1
2. Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids
3. Characterization of interleukin-1alpha binding to mouse brain endothelial cells
4. The CRF1 receptor mediates the excitatory action of corticotropin releasing factor (CRF) in the developing rat brain: In vivo evidence using a novel selective, non-peptide CRF receptor antagonist
5. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
6. In vitro pharmacological profile of nonpeptide CRF1 receptor antagonist, CRA1000 and CRA 1001
7. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
8. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
9. Role of interleukin-1α and 1β in endotoxin-induced suppression of plasma gonadotropin levels in rats
10. Corticotropin releasing factor modulates interleukin-1-induced prostaglandin synthesis in fibroblasts: Receptor binding and effects of antagonists
11. Interleukin-1 receptors type I and type II in the mouse brain: Kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharide
12. Interleukin-1 receptors in brain and pituitary: Characterization and modulation during infection and stress
13. Interleukine-1 receptors in the brain: Characterization by quantitaive in situ autoradiography
14. Corticotropin-releasing factor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats
15. Augmentation of type I IL-1 receptor expression and IL-1 signaling by IL-6 and glucocorticoid in murine hepatocytes
16. A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity
17. Modulation of type I interleukin-1 receptor messenger RNA followed by one and repeated endotoxin treatment in the mouse
18. Differential effects of one and repeated endotoxin treatment on pituitary-adrenocortical hormones in the mouse: Role of interleukin-1 and tumor necrosis factor-α
19. Receptor-binding, behavioral and electrophysiological profiles of non-peptide CRF1 receptor antagonists, CRA 1000 and CRA 1001
20. Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin
21. In the rat, interleukin-1a acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion
22. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
23. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
24. Reciprocal modulation of interleukin-β (IL-1β) and IL-1 receptors by lipopolysaccharide (endotoxin) treatment in the mouse brain-endocrine-immune axis
25. Cyclic AMP-dependent modulation of interleukin-1 receptors in the mouse AtT-20 pituitary tumor cell line
26. Regulation of interleukin-1 receptors and hypothalamic-pituitary-adrenal axis by lipopolysaccharide treatment in the mouse
27. Corticotropin-releasing factor treatment up-regulates interleukin-1 receptors in the mouse pituitary: Reversal by dexamethasone
28. Reciprocal modulation of corticotropin-releasing factor and interleukin-1 receptors following ether-laparotomy stress in the mouse
29. Stress-induced upregulation of pituitary interleukin-1 receptors is mediated by corticotropin releasing factor
30. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin-releasing factor
31. Upregulation of interleukin-1 receptors in mouse AtT-20 pituitary tumor cells following treatment with corticotropin-releasing factor
32. Stress-induced behaviors require the corticotropin releasing hormone (CRH) receptor, but not CRH
33. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis response to acute immobilization stress